Legislative Services  |  Legislative Audits
Bill number does not exist. Enter a vaild keyword.
Facebook Twitter Youtube Channels
facebook twitter
Facebook Twitter
Click to add bill to MyMGA list

HB0417

Original
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Opposite
Chamber
1st
Reading
Referral
to Cmte
2nd
Reading
3rd
Reading
Review in
Original Chamber
Passed Both
Chambers
Conf. Cmte
(if necessary)
To Governor
Title
Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Sponsored by
Delegates Pippy, Kerr, Alston, Bagnall, Cullison, Guzzone, Hill, Hutchinson, S. Johnson, Kaufman, Kipke, Lopez, Martinez, M. Morgan, Reilly, Rosenberg, Ross, Szeliga, Taveras, White Holland, and Woorman
Status
In the Senate - First Reading Finance
Analysis
Fiscal and Policy Note
Synopsis
Establishing medetomidine and xylazine as Schedule III controlled dangerous substances under the Maryland Controlled Dangerous Substances Act
Committees
Original:
Health   Click to view Recorded Media
Opposite:
Finance
Committee Testimony
Witness List
Details
Cross-filed with: SB0435
Introduced in a prior session as: HB1109 Session: 2025 Regular Session
Bill File Type: Regular
Effective Date(s): October 1, 2026
History
Legislation History
Chamber
House
Calendar Date
1/22/2026
Legislative Date
1/22/2026
Action
First Reading Health
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act
Proceedings
Chamber
House
Calendar Date
1/22/2026
Legislative Date
1/22/2026
Action
Hearing 2/10 at 2:00 p.m.
Proceedings
Chamber
House
Calendar Date
2/10/2026
Legislative Date
2/10/2026
Action
Hearing canceled
Proceedings
Chamber
House
Calendar Date
2/10/2026
Legislative Date
2/10/2026
Action
Hearing 2/10 at 2:30 p.m.
Proceedings
Chamber
Calendar Date
Legislative Date
Action
Vote - House - Committee - Health
Proceedings
Click to view Recorded Media
Chamber
House
Calendar Date
3/03/2026
Legislative Date
3/03/2026
Action
Favorable with Amendments Report by Health
Proceedings
Chamber
House
Calendar Date
3/03/2026
Legislative Date
2/22/2026
Action
Favorable with Amendments {953328/1 Adopted
Proceedings
31 Click to view Recorded Media
Chamber
House
Calendar Date
3/03/2026
Legislative Date
2/22/2026
Action
Second Reading Passed with Amendments
Proceedings
31 Click to view Recorded Media
Chamber
Calendar Date
Legislative Date
Action
Text - Third - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
Proceedings
Chamber
House
Calendar Date
3/04/2026
Legislative Date
2/23/2026
Action
Third Reading Passed (127-0)
Proceedings
32 Click to view Recorded Media
Chamber
Senate
Calendar Date
3/05/2026
Legislative Date
2/22/2026
Action
Referred Finance
Proceedings
33 Click to view Recorded Media
Chamber Calendar Date Legislative Date Action Proceedings
House 1/22/2026 1/22/2026 First Reading Health
Text - First - Public Health - Medetomidine and Xylazine Consumer Protection Act
House 1/22/2026 1/22/2026 Hearing 2/10 at 2:00 p.m.
House 2/10/2026 2/10/2026 Hearing canceled
House 2/10/2026 2/10/2026 Hearing 2/10 at 2:30 p.m.
Vote - House - Committee - Health Click to view Recorded Media
House 3/03/2026 3/03/2026 Favorable with Amendments Report by Health
House 3/03/2026 2/22/2026 Favorable with Amendments {953328/1 Adopted 31 Click to view Recorded Media
House 3/03/2026 2/22/2026 Second Reading Passed with Amendments 31 Click to view Recorded Media
Text - Third - Criminal Law - Schedule III Controlled Dangerous Substances - Medetomidine and Xylazine
House 3/04/2026 2/23/2026 Third Reading Passed (127-0) 32 Click to view Recorded Media
Senate 3/05/2026 2/22/2026 Referred Finance 33 Click to view Recorded Media
File Code
Subjects
Statutes
Last Updated: 3/30/2026 2:46 PM
Click to return on the top page